Primary hyperoxaluria type 1 in The Netherlands: Prevalence and outcome

Nephrology Dialysis Transplantation

Volumn 18, Issue 2, 2003, Pages 273-279

  van Woerden, Christiaan S ^a,b   Groothoff, Jaap W ^a   Wanders, Ronald J A ^a,b   Davin, Jean Claude ^a   Wijburg, Frits A ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Hyperoxaluria; Nephrocalcinosis; Pyridoxine responsiveness; Renal insufficiency; Survival

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; PYRIDOXINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BIOCHEMISTRY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG RESPONSE; DRUG SENSITIVITY; ECHOGRAPHY; ENZYME ACTIVITY; FOLLOW UP; HUMAN; INCIDENCE; INFANT; KIDNEY CALCIFICATION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEPHROLOGY; NETHERLANDS; OXALOSIS 1; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPEROXALURIA, PRIMARY; INCIDENCE; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROCALCINOSIS; NETHERLANDS; PREVALENCE; RENAL DIALYSIS; RISK; SURVIVAL ANALYSIS;

EID: 0037317074     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.2.273     Document Type: Article

References (27)

1. Danpure CJ, Jennings PR. Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 1986; 201: 20-24
2. Giafi CF, Rumsby G. Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2. Ann Clin Biochem 1998; 35: 104-109
3. Neuhaus TJ, Belzer T, Blau N, Hoppe B, Sidhu H, Leumann E. Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 2000; 82: 322-326
4. Latta K, Brodehl J. Primary hyperoxaluria type 1. Eur J Pediatr 1990; 149: 518-522
5. Cochat P, Deloraine A, Rotily M et al. on behalf of the Société de Néphrologie and the Société de Néphrologie Pédiatrique: Epidemiology of primary hyperoxaluria type 1. Nephrol Dial Transplant 1995; 10 [Suppl 8]: S3-S7
6. Milliner DS, Wilson DM, Smith LH. Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2. J Nephrol 1998; 11 [Suppl 1]: S56-S59
7. Danpure CJ. Molecular and clinical heterogeneity in primary hyperoxaluria type 1. Am J Kidney Dis 1991; 17: 366-369
8. Danpure CJ, Purdue PE. Primary hyperoxaluria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, ed. The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York: 1995; 2385
9. Milliner DS, Eickholt JT, Bergstralh et al. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 1994; 331: 1553-1558
10. Leumann E, Hoppe B, Neuhaus T, Blau N. Efficacy of oral citrate administration in primary hyperoxaluria. Nephrol Dial Transplant 1995; 10 [Suppl 8]: S14-S16
11. Broyer M, Jouvet P, Niaudet P, Daudon M, Revillon Y. Management of oxalosis. Kidney Int 1996; 53: S93-S98
12. Cochat P, Gaulier JM, Koch Nogueira PC et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 1999; 158 [Suppl 2]: S75-S80
13. Cochat P, Basmaison O. Current approaches to the management of primary hyperoxaluria. Arch Dis Child 2000; 82: 470-473
14. Reusz GS, Dobos M, Byrd D, Sallay P, Miltenyi M, Tulassay T. Urinary calcium oxalate excretion in children. Pediatr Nephrol 1995; 9: 39-44
15. Wolthers BG, Meijer S, Tepper T, Hayer M, Elzinga H. The determination of oxalate in haemodialysate and plasma: a means to detect and study 'hyperoxaluria' in haemodialysed patients. Clin Sci 1986; 71: 41-47
16. Leumann E, Hoppe B. What is new in primary hyperoxaluria? Nephrol Dial Transplant 1999; 14: 2556-2558
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
18. Schwartz GJ, Haycock GB, Edelmann CM, Jr et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263
19. Horvath VAP, Wanders RJA. Amino-oxyacetic acid: a selective inhibitor of alanine:glyoxylate aminotransferase and its use in the diagnosis of primary hyperoxaluria type I. Clin Chim Acta 1995; 243: 105-114
20. Danpure CJ. Primary hyperoxaluria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, ed. The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York: 2001; 3331
21. Kopp N, Leumann E. Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 1995; 10: 2224-2227
22. Cochat P, Koch Nogueira PC, Ayman Mahmoud MA et al. Primary hyperoxaluria in infants: medical, ethical and economic issues. J Pediatr 1999; 135: 746-750
23. Toussaint C. Pyridoxine-responsive PH1: treatment. J Nephrol 1998; 11 [Suppl 1]: 49-50
24. Dick PT, Shuckett BM, Tang B, Daneman A, Kooh SW. Observer reliability in grading nephrocalcinosis on ultrasound examinations in children. Pediatr Radiol 1999; 29: 68-72
25. van Buren M. A stony history. Nephrol Dial Transplant 2000; 15: 551-553
26. Scheid C, Koul H, Hill WA et al. Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 1996; 49: 413-419
27. Singh DR, Sagade SN, Kamat MH et al. Oxalosis with nephrocalcinosis. Nephrol Dial Transplant 2000; 15: 124-125